Cancer Research Meeting Calendar Advances in Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Selzer, E.
Right arrow Articles by Jansen, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Selzer, E.
Right arrow Articles by Jansen, B.
[Cancer Research 62, 2098-2103, April 1, 2002]
© 2002 American Association for Cancer Research

Tumor Biology

The Melanocyte-specific Isoform of the Microphthalmia Transcription Factor Affects the Phenotype of Human Melanoma1

Edgar Selzer2, Volker Wacheck, Trevor Lucas, Elisabeth Heere-Ress, Min Wu, Katherine N. Weilbaecher, Werner Schlegel, Peter Valent, Fritz Wrba, Hubert Pehamberger, David Fisher and Burkhard Jansen

Department of Radiotherapy and Radiobiology [E. S., W. S.], Department of Clinical Pharmacology, Section of Experimental Oncology and Molecular Pharmacology [V. W., T. L., B. J.], Department of Dermatology, Division of General Dermatology [T. L., E. H-R., H. P., B. J.], Department of Internal Medicine I, Division of Hematology and Hemostaseology [P. V.], Department of Clinical Pathology [F. W.], Ludwig Boltzmann Institute for Clinical and Experimental Oncology [H. P.], and Center of Excellence for Clinical and Experimental Oncology, [E. S., H. P.], University Hospital Vienna, 1090 Vienna, Austria; Department of Pediatric Hematology/Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115 [M. W., K. N. W., D. F.]; and Department of Medical Oncology, Washington University, St. Louis, Missouri 63110 [K. N. W.]

The microphthalmia transcription factor MITF plays a pivotal role in the development and differentiation of melanocytes. The purpose of this work was to investigate the expression and function of the melanocyte-specific isoform MITF-M in human melanoma. We found that MITF-M is repressed in 8 of 14 established melanoma cell lines tested. Transfection of MITF-M into a melanoma cell line (518A2) lacking the M-isoform and into a permanent cell line established from normal melanocytes (NMel-II) resulted in slower tumor growth in a severe combined immunodeficient-mouse xenotransplantation model. The growth difference between vector control-transfected tumors derived from the NMel-II cell line (mean tumor weight ± SD, 3.2 g ± 1.13) and MITF-M (+) transfectants (mean tumor weight ± SD, 1.1 g ± 0.49) was significant (P = 0.018). The mean tumor weight of control-transfected 518A2 tumors was 0.99 g ± 0.22 and of MITF-M (+) transfectants, 0.69 g ± 0.32. The difference in growth between 518A2 controls and the MITF-M (+) transfectants was clear, however it did not reach statistical significance (P = 0.08). In addition to the growth-inhibitory effects, MITF-M expression led to a change in the histopathological appearance of tumors from epitheloid toward a spindle-cell type in vivo. These results indicate a role for the MITF-M isoform in the in vivo growth control and the phenotype of human melanoma. In conclusion, MITF-M may qualify as a marker capable of identifying subgroups of melanoma patients with different tumor biology and prognosis.




This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
M. F. Segura, D. Hanniford, S. Menendez, L. Reavie, X. Zou, S. Alvarez-Diaz, J. Zakrzewski, E. Blochin, A. Rose, D. Bogunovic, et al.
Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor
PNAS, February 10, 2009; 106(6): 1814 - 1819.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
W. van Gils, E. M. Lodder, H. W. Mensink, E. Kilic, N. C. Naus, H. T. Bruggenwirth, W. van IJcken, D. Paridaens, G. P. Luyten, and A. de Klein
Gene Expression Profiling in Uveal Melanoma: Two Regions on 3p Related to Prognosis
Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4254 - 4262.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Ugurel, R. Houben, D. Schrama, H. Voigt, M. Zapatka, D. Schadendorf, E. B. Brocker, and J. C. Becker
Microphthalmia-Associated Transcription Factor Gene Amplification in Metastatic Melanoma Is a Prognostic Marker for Patient Survival, But Not a Predictive Marker for Chemosensitivity and Chemotherapy Response
Clin. Cancer Res., November 1, 2007; 13(21): 6344 - 6350.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
B. Stecca, C. Mas, V. Clement, M. Zbinden, R. Correa, V. Piguet, F. Beermann, and A. Ruiz i Altaba
Melanomas require HEDGEHOG-GLI signaling regulated by interactions between GLI1 and the RAS-MEK/AKT pathways
PNAS, April 3, 2007; 104(14): 5895 - 5900.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
S. Carreira, J. Goodall, L. Denat, M. Rodriguez, P. Nuciforo, K. S. Hoek, A. Testori, L. Larue, and C. R. Goding
Mitf regulation of Dia1 controls melanoma proliferation and invasiveness
Genes & Dev., December 15, 2006; 20(24): 3426 - 3439.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
A. Schepsky, K. Bruser, G. J. Gunnarsson, J. Goodall, J. H. Hallsson, C. R. Goding, E. Steingrimsson, and A. Hecht
The Microphthalmia-Associated Transcription Factor Mitf Interacts with {beta}-Catenin To Determine Target Gene Expression
Mol. Cell. Biol., December 1, 2006; 26(23): 8914 - 8927.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. Koyanagi, S. J. O'Day, R. Gonzalez, K. Lewis, W. A. Robinson, T. T. Amatruda, C. Kuo, H.-J. Wang, R. Milford, D. L. Morton, et al.
Microphthalmia Transcription Factor as a Molecular Marker for Circulating Tumor Cell Detection in Blood of Melanoma Patients
Clin. Cancer Res., February 15, 2006; 12(4): 1137 - 1143.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
L. Larribere, C. Hilmi, M. Khaled, C. Gaggioli, K. Bille, P. Auberger, J. P. Ortonne, R. Ballotti, and C. Bertolotto
The cleavage of microphthalmia-associated transcription factor, MITF, by caspases plays an essential role in melanocyte and melanoma cell apoptosis
Genes & Dev., September 1, 2005; 19(17): 1980 - 1985.
[Abstract] [Full Text] [PDF]

Home page
 JCBHome page
C. Wellbrock and R. Marais
Elevated expression of MITF counteracts B-RAF-stimulated melanocyte and melanoma cell proliferation
J. Cell Biol., August 29, 2005; 170(5): 703 - 708.
[Abstract] [Full Text] [PDF]

Home page
 JCBHome page
R. Busca, E. Berra, C. Gaggioli, M. Khaled, K. Bille, B. Marchetti, R. Thyss, G. Fitsialos, L. Larribere, C. Bertolotto, et al.
Hypoxia-inducible factor 1{alpha} is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells
J. Cell Biol., July 4, 2005; 170(1): 49 - 59.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. J. Miller, J. Du, S. Rowan, C. L. Hershey, H. R. Widlund, and D. E. Fisher
Transcriptional Regulation of the Melanoma Prognostic Marker Melastatin (TRPM1) by MITF in Melanocytes and Melanoma
Cancer Res., January 15, 2004; 64(2): 509 - 516.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
R. P. Kuiper, M. Schepens, J. Thijssen, M. van Asseldonk, E. van den Berg, J. Bridge, E. Schuuring, E. F.P.M. Schoenmakers, and A. G. van Kessel
Upregulation of the transcription factor TFEB in t(6;11)(p21;q13)-positive renal cell carcinomas due to promoter substitution
Hum. Mol. Genet., July 15, 2003; 12(14): 1661 - 1669.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
J. Du, A. J. Miller, H. R. Widlund, M. A. Horstmann, S. Ramaswamy, and D. E. Fisher
MLANA/MART1 and SILV/PMEL17/GP100 Are Transcriptionally Regulated by MITF in Melanocytes and Melanoma
Am. J. Pathol., July 1, 2003; 163(1): 333 - 343.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.